Citius Pharmaceuticals, Inc. Increase (Decrease) in Other Receivables
Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Other Receivables of -$818.34 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2020-12-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2020-12-16
- Citius Pharmaceuticals, Inc. increase (decrease) in other receivables for the quarter ending 2019-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. increase (decrease) in other receivables for the quarter ending 2019-06-30 was $0.00.
- Citius Pharmaceuticals, Inc. increase (decrease) in other receivables for the quarter ending 2019-03-31 was $0.00.
- Citius Pharmaceuticals, Inc. increase (decrease) in other receivables for the quarter ending 2018-12-31 was -$818.34K.
- Citius Pharmaceuticals, Inc. increase (decrease) in other receivables for fiscal 2019 was -$818.34K, a 200.00% decline from fiscal 2018.
- Citius Pharmaceuticals, Inc. increase (decrease) in other receivables for fiscal 2018 was $818.34K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | $0.00 derived: sum of 2 quarters · filed 2020-12-16 | $0.00 derived: sum of 3 quarters · filed 2020-12-16 | -$818.34K 10-K · filed 2020-12-16 |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | $0.00 derived: sum of 2 quarters · filed 2020-08-14 | -$818.34K 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | -$818.34K 10-Q · filed 2020-05-14 | ||
| 2018-12-31 | -$818.34K 10-Q · filed 2020-02-13 | |||
| 2018-09-30 | $818.34K 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |